Algert Global’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Sell
15,003
-639
-4% -$653K 0.21% 109
2026
Q1
$14.4M Buy
15,642
+766
+5% +$777K 0.22% 127
2025
Q4
$16M Sell
14,876
-272
-2% -$260K 0.25% 93
2025
Q3
$11.6M Buy
15,148
+1,502
+11% +$1.12M 0.19% 153
2025
Q2
$10.6M Buy
13,646
+540
+4% +$420K 0.22% 118
2025
Q1
$10.8M Buy
13,106
+848
+7% +$706K 0.27% 84
2024
Q4
$9.46M Buy
12,258
+1,372
+13% +$1.14M 0.22% 124
2024
Q3
$9.64M Buy
10,886
+10,382
+2,060% +$9.33M 0.26% 85
2024
Q2
$456K Buy
504
+110
+28% +$88K 0.02% 949
2024
Q1
$307K Sell
394
-640
-62% -$455K 0.01% 891
2023
Q4
$603K Buy
1,034
+60
+6% +$35K 0.02% 762
2023
Q3
$523K Sell
974
-4,459
-82% -$2.3M 0.02% 729
2023
Q2
$2.55M Buy
5,433
+274
+5% +$115K 0.11% 313
2023
Q1
$1.77M Buy
5,159
+700
+16% +$236K 0.08% 389
2022
Q4
$1.63M Buy
+4,459
New +$1.58M 0.09% 368
2022
Q3
– Sell
-5,862
Closed -$1.9M – 1251
2022
Q2
$1.9M Buy
+5,862
New +$1.76M 0.14% 209
2014
Q1
– Sell
-53,560
Closed -$2.73M – 345
2013
Q4
$2.73M Buy
+53,560
New +$2.68M 0.73% 24

Other funds holding LLY

Algert Global's LLY Position: Q2 2026 in Review

Algert Global reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $653K and leaving 15,003 shares worth $18M. The position accounts for 0.21% of the portfolio, ranked #109.

Algert Global first reported a position in LLY in Q4 2013 and has held it in 17 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Algert Global held 15,003 shares of Eli Lilly worth $18M as of Q2 2026.
  • Algert Global sold 639 Eli Lilly shares in Q2 2026, an estimated $653K.
  • Eli Lilly made up 0.21% of Algert Global's portfolio in Q2 2026, its #109 holding.
  • Algert Global first reported a position in Eli Lilly in Q4 2013 and has held it in 17 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.